Influenza

Influenza: Causes, Symptoms, Prevention, and Management

~Introduction

Influenza, commonly referred to as the flu, is an acute viral infection that affects the respiratory system, including the nose, throat, and lungs. Unlike the common cold, influenza tends to strike suddenly and can cause more severe symptoms, sometimes leading to serious complications and even death, particularly in vulnerable populations such as young children, the elderly, pregnant women, and people with chronic medical conditions.

This contagious disease has a significant impact on global public health every year, resulting in millions of cases and hundreds of thousands of deaths worldwide. Seasonal influenza outbreaks occur mainly in the colder months in temperate climates, but the virus circulates year-round in tropical regions.

---

~History and Global Impact

The history of influenza pandemics shows the immense potential of the virus to cause widespread illness and death. The most devastating example is the 1918 Spanish flu pandemic, which infected an estimated 500 million people (about one-third of the world’s population at the time) and resulted in approximately 50 million deaths.

Subsequent pandemics, such as the Asian flu (1957), the Hong Kong flu (1968), and the H1N1 pandemic (2009), highlighted the virus’s ability to mutate and cause sudden outbreaks. Today, the World Health Organization (WHO) monitors influenza activity globally, promoting prevention strategies and early detection to reduce impact.

---

~Causes and Types of Influenza Viruses

Influenza is caused by viruses belonging to the Orthomyxoviridae family. There are four main types:

1. Influenza A

   • The most common and often the most severe.

     
     
     

   • Responsible for seasonal epidemics and pandemics.

   • Subtyped based on two proteins on the virus surface:

     • Hemagglutinin (H) – 18 known types.

     • Neuraminidase (N) – 11 known types.

   • Examples: H1N1, H3N2.

2. Influenza B

   • Causes seasonal epidemics, but not pandemics.

   • No subtypes but divided into two main lineages: B/Yamagata and B/Victoria.

   • Typically, less severe than influenza A but can still cause serious illness.

3. Influenza C

   • Causes mild respiratory illness and is not associated with epidemics.

   • Less common than types A and B.

4. Influenza D

   • Primarily affects cattle and is not known to infect humans.

---

~Transmission and Spread

Influenza viruses are highly contagious and spread mainly through respiratory droplets when an infected person coughs, sneezes, or talks. These droplets can land in the mouths or noses of nearby people or be inhaled into the lungs.

Modes of Transmission:

• Droplet Transmission: The most common route.

• Airborne Transmission: Smaller virus-containing particles can remain suspended in the air for a short time.

• Contact Transmission: Touching contaminated surfaces and then touching the face.

Contagious Period:

• Adults can spread the virus from 1 day before symptoms appear to about 5–7 days after becoming sick.

• Children and people with weakened immune systems may remain contagious for longer.

---

~Risk Factors

Certain individuals are at higher risk of developing severe complications from influenza:

• Age: Young children (under 5, especially under 2) and adults over 65.

• Pregnancy: Especially in the second and third trimesters.

• Chronic Conditions: Heart disease, diabetes, asthma, lung diseases.

• Weakened Immune System: Due to illnesses such as HIV/AIDS or treatments like chemotherapy.

• Living Conditions: Nursing homes, military barracks, and crowded environments increase risk.

---

~Signs and Symptoms

Influenza symptoms often develop suddenly and may include:

• High fever (though not everyone with the flu will have a fever)

• Chills and sweats

• Cough

• Sore throat

• Runny or stuffy nose

• Muscle or body aches

• Headache

• Fatigue (tiredness)

• Occasionally, vomiting and diarrhea (more common in children)

Difference from the Common Cold:
While both illnesses affect the respiratory tract, flu symptoms are more intense, appear suddenly, and are more likely to lead to complications.

---

~Complications

Influenza can lead to serious health problems, especially in high-risk groups. Common complications include:

• Pneumonia (viral or secondary bacterial)

• Bronchitis

• Asthma exacerbations

• Sinus and ear infections

• Myocarditis (inflammation of the heart muscle)

• Encephalitis (brain inflammation)

• Multi-organ failure in severe cases

---

~Diagnosis

Influenza diagnosis is based on clinical symptoms and sometimes confirmed with laboratory tests, especially during peak flu season.

Common Diagnostic Methods:

1. Rapid Influenza Diagnostic Tests (RIDTs):

   • Provide results in 10–15 minutes.

   • Detect viral antigens.

   • Less sensitive than molecular tests.

2. Rapid Molecular Assays:

   • Detect viral RNA.

   • More accurate than RIDTs.

3. RT-PCR (Reverse Transcription Polymerase Chain Reaction):

   • Highly sensitive and specific.

   • Identifies influenza type and subtype.

4. Viral Culture:

   • Used mainly for research or public health surveillance.

---

~Treatment

Most healthy individuals recover without medical treatment, but antiviral medications can reduce the severity and duration of symptoms if started within 48 hours of symptom onset.

Antiviral Medications:

1. Oseltamivir (Tamiflu)

2. Zanamivir (Relenza)

3. Peramivir (Rapivab)

4. Baloxavir marboxil (Xofluza) – Single-dose treatment.

These drugs:

• Shorten illness by 1–2 days.

• Reduce risk of complications.

• Are most effective when started early.

Supportive Care:

• Rest and hydration.

• Fever reducers and pain relievers (paracetamol, ibuprofen).

• Avoid aspirin in children due to risk of Reye’s syndrome.

---

~Prevention

1. Vaccination

Annual influenza vaccination is the most effective prevention strategy. Since the virus mutates rapidly, vaccines are updated yearly to match circulating strains.

Types of Influenza Vaccines:

• Inactivated Influenza Vaccine (IIV): Given as an injection.

• Live Attenuated Influenza Vaccine (LAIV): Nasal spray form, used in certain age groups.

• Recombinant Influenza Vaccine (RIV): Egg-free production.

Target Groups for Vaccination:

• All individuals over 6 months of age.

• Especially important for high-risk groups and healthcare workers.

---

2. Hygiene Measures

• Frequent handwashing with soap and water.

• Using alcohol-based hand sanitizers.

• Avoiding close contact with sick people.

• Covering mouth and nose when coughing or sneezing.

• Avoiding touching the face.

---

3. Environmental Controls

• Regular cleaning of frequently touched surfaces.

• Good ventilation in indoor spaces.

---

~Influenza vs. COVID-19

Flu virus

Since 2020, distinguishing influenza from COVID-19 has been important because symptoms overlap. Both are contagious respiratory illnesses, but they are caused by different viruses (influenza viruses vs. SARS-CoV-2). Testing is often required to confirm which virus is responsible, especially during seasons when both are circulating.

---

~Myths and Misconceptions

1. “Flu is just a bad cold.”

   • False. Influenza can be life-threatening, especially in vulnerable groups.

2. “The flu vaccine can give you the flu.”

   • False. Inactivated vaccines cannot cause influenza.

3. “Healthy people don’t need the vaccine.”

   • False. Even healthy individuals can contract the flu and spread it to others.

---

~Public Health Response

• Surveillance: Monitoring flu activity worldwide to detect emerging strains.

• Preparedness: Stockpiling antivirals and vaccines.

• Pandemic Planning: Rapid response strategies for outbreaks.

• Education: Public awareness campaigns on prevention.

---

~Conclusion

Influenza remains a significant global health threat due to its contagious nature, potential severity, and ability to mutate rapidly. Annual vaccination, good hygiene practices, and early medical attention are the best defenses against the disease. While most people recover within a week or two, high-risk individuals must take special precautions to avoid complications.

Public health systems must remain vigilant, as influenza viruses will continue to evolve. With ongoing research, improved vaccines, and rapid diagnostics, the goal is to reduce the impact of seasonal and pandemic influenza worldwide.